Bioscience Neutraceuticals Inc logo

DEVV - Bioscience Neutraceuticals Inc Share Price

$0.05 0.0  0.0%

Last Trade - 11/02/21

Sector
Industrials
Size
Micro Cap
Market Cap £289k
Enterprise Value £422k
Revenue £n/a
Position in Universe 6607th / 6647
Bullish
Bearish
Unlock DEVV Revenue
Momentum
Relative Strength (%)
1m +398.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -99.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019,Bioscience Neutraceuticals Inc revenues was not reported.Net loss before extraordinary items increased from $61K to$626K. Higher net loss reflects Interest expense increasefrom $25K to $166K (expense), General and administrativeincrease of 71% to $4K (expense), Professional remainingflat at $34K (expense). Basic Earnings per Share excludingExtraordinary Items increased from -$0.25 to -$0.10.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

DEVV Revenue Unlock DEVV Revenue

Net Income

DEVV Net Income Unlock DEVV Revenue

Normalised EPS

DEVV Normalised EPS Unlock DEVV Revenue

PE Ratio Range

DEVV PE Ratio Range Unlock DEVV Revenue

Dividend Yield Range

DEVV Dividend Yield Range Unlock DEVV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
DEVV EPS Forecasts Unlock DEVV Revenue
Profile Summary

Bioscience Neutraceuticals, Inc., formerly JobLocationMap Inc., is a shell company. The Company is engaged in the development of visual job search service, which is focused on putting together job seekers and employers in JobLocationMap.com. Its Website intends to provide job seekers and employers with a platform to share their valid address and contact information to be shown as a pin on its provided map, manage their job description or their resume, and interact with a community of job searcher and employers from around the world. The Company is building an App for use with iPhone and Android. The App is focused on allowing users to search job listings to find a job location by map or use the App job search or browse jobs to find employment opportunities in an individual's area. The App seeks to connect people to job opportunities, Website global recruitment network, and to JobLocationMap platform.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated June 15, 2010
Public Since December 9, 2013
No. of Shareholders: n/a
No. of Employees: n/a
Sector Industrials
Industry Professional & Commercial Services
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 8,042,516
Free Float (0.0%)
Eligible for
ISAs
SIPPs
DEVV Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DEVV
Upcoming Events for DEVV
Frequently Asked Questions for Bioscience Neutraceuticals Inc
What is the Bioscience Neutraceuticals Inc share price?

As of 11/02/21, shares in Bioscience Neutraceuticals Inc are trading at $0.05, giving the company a market capitalisation of £289k. This share price information is delayed by 15 minutes.

How has the Bioscience Neutraceuticals Inc share price performed this year?

Shares in Bioscience Neutraceuticals Inc are currently trading at $0.05 and the price has moved by -97.49% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioscience Neutraceuticals Inc price has moved by -98.03% over the past year.

What are the analyst and broker recommendations for Bioscience Neutraceuticals Inc?

There are no analysts currently covering Bioscience Neutraceuticals Inc.

When will Bioscience Neutraceuticals Inc next release its financial results?

Bioscience Neutraceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Bioscience Neutraceuticals Inc dividend yield?

Bioscience Neutraceuticals Inc does not currently pay a dividend.

Does Bioscience Neutraceuticals Inc pay a dividend?

Bioscience Neutraceuticals Inc does not currently pay a dividend.

When does Bioscience Neutraceuticals Inc next pay dividends?

Bioscience Neutraceuticals Inc does not currently pay a dividend.

How do I buy Bioscience Neutraceuticals Inc shares?

To buy shares in Bioscience Neutraceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bioscience Neutraceuticals Inc?

Shares in Bioscience Neutraceuticals Inc are currently trading at $0.05, giving the company a market capitalisation of £289k.

Where are Bioscience Neutraceuticals Inc shares listed? Where are Bioscience Neutraceuticals Inc shares listed?

Here are the trading details for Bioscience Neutraceuticals Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: DEVV
What kind of share is Bioscience Neutraceuticals Inc?

Based on an overall assessment of its quality, value and momentum, Bioscience Neutraceuticals Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Bioscience Neutraceuticals Inc share price forecast 2021?

We were not able to load any forecast data for Bioscience Neutraceuticals Inc.

How can I tell whether the Bioscience Neutraceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioscience Neutraceuticals Inc. Over the past six months, the relative strength of its shares against the market has been -79.65%. At the current price of $0.05, shares in Bioscience Neutraceuticals Inc are trading at -97.61% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bioscience Neutraceuticals Inc PE Ratio?

We were not able to find PE ratio data for Bioscience Neutraceuticals Inc.

Who are the key directors of Bioscience Neutraceuticals Inc?

Bioscience Neutraceuticals Inc's management team is headed by:

Liang Chen - CEO
Who are the major shareholders of Bioscience Neutraceuticals Inc?

Here are the top five shareholders of Bioscience Neutraceuticals Inc based on the size of their shareholding:

Chen (Liang) Individual Investor
Percentage owned: 87.1% (7.01m shares)
Peak Global Consultants Ltd Corporation
Percentage owned: 2.49% (200k shares)
Bay Harbor Wealth Management, LLC Investment Advisor
Percentage owned: % (n/a shares)
Similar to DEVV
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.